PHARMETAL: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMETAL
Largest movements
- Cash -€8,285
down €8,285 (-69.8%), from €11,864 to €3,578
mainly Net result for the year (-€18,466) and Other debts (-€931)
- Profit (loss) carried forward -€18,466
down €18,466 (-9.4%), from €196,694 to €178,228
- Financial income -€22,412
down €22,412 (-82.0%), from €27,326 to €4,914
- Financial charges +€20,038
up €20,038 (+8,779%), from €228 to €20,266
- Taxes -€6,417
down €6,417 (-90.6%), from €7,083 to €666
- Gross operating margin +€1,175
up €1,175 (+39.5%), from -€2,976 to -€1,800
- Other operating charges -€41
down €41 (-9.2%), from €440 to €400
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €394,375 | €375,906 | -€18,469 | -4.7% |
| Fixed assets | 21/28 | €714 | €467 | -€247 | -34.6% |
| Tangible fixed assets | 22/27 | €518 | €271 | -€247 | -47.7% |
| Plant, machinery and equipment | 23 | €518 | €271 | -€247 | -47.7% |
| Furniture and vehicles | 24 | €0 | €0 | = | |
| Financial fixed assets | 28 | €196 | €196 | = | 0.0% |
| Current assets | 29/58 | €393,661 | €375,439 | -€18,222 | -4.6% |
| Amounts receivable within one year | 40/41 | €3,377 | €189 | -€3,188 | -94.4% |
| Other amounts receivable | 41 | €3,377 | €189 | -€3,188 | -94.4% |
| Current investments | 50/53 | €373,865 | €370,820 | -€3,044 | -0.8% |
| Cash at bank and in hand | 54/58 | €11,864 | €3,578 | -€8,285 | -69.8% |
| Deferred charges and accrued income | 490/1 | €4,556 | €851 | -€3,704 | -81.3% |
| Total equity and liabilities | 10/49 | €394,375 | €375,906 | -€18,469 | -4.7% |
| Equity | 10/15 | €390,295 | €371,829 | -€18,466 | -4.7% |
| Reserves | 13 | €193,601 | €193,601 | = | 0.0% |
| Distributable reserves | 133 | €193,601 | €193,601 | = | 0.0% |
| Profit (loss) carried forward | 14 | €196,694 | €178,228 | -€18,466 | -9.4% |
| Amounts payable | 17/49 | €4,081 | €4,077 | -€4 | -0.1% |
| Amounts payable within one year | 42/48 | €4,081 | €4,077 | -€4 | -0.1% |
| Trade debts | 44 | €170 | €1,905 | +€1,735 | +1,020% |
| Suppliers | 440/4 | €170 | €1,905 | +€1,735 | +1,020% |
| Taxes, remuneration and social security | 45 | €2,980 | €2,172 | -€808 | -27.1% |
| Taxes | 450/3 | €2,980 | €2,172 | -€808 | -27.1% |
| Other amounts payable | 47/48 | €931 | - | -€931 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €247 | €247 | = | 0.0% |
| Other operating charges | 640/8 | €440 | €400 | -€41 | -9.2% |
| Gross operating margin | 9900 | -€2,976 | -€1,800 | +€1,175 | +39.5% |
| Operating profit (loss) | 9901 | -€3,663 | -€2,447 | +€1,216 | +33.2% |
| Financial income | 75/76B | €27,326 | €4,914 | -€22,412 | -82.0% |
| Recurring financial income | 75 | €27,326 | €4,914 | -€22,412 | -82.0% |
| Financial charges | 65/66B | €228 | €20,266 | +€20,038 | +8,779% |
| Recurring financial charges | 65 | €228 | €20,266 | +€20,038 | +8,779% |
| Profit (loss) for the period before taxes | 9903 | €23,434 | -€17,799 | -€41,234 | |
| Income taxes | 67/77 | €7,083 | €666 | -€6,417 | -90.6% |
| Profit (loss) for the period | 9904 | €16,351 | -€18,466 | -€34,817 | |
| Profit (loss) for the period to be appropriated | 9905 | €16,351 | -€18,466 | -€34,817 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 17 October 2026 via checked.be.